# K053160: Micrus Modified Microcoil 18-System, Cerecyte, Model CSP & Che

- Pathway: 510(k) (Special)
- Applicant: Micrus Endovascular Corporation
- Decided: Dec 7, 2005 after 23 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K951256 (1995). 27 ancestors in all.
35 later devices descend from it; 3 cite it directly.
1 of 63 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K033813: Micrus Modified Microcoil System, Cerecyte, Micrus Corp. (2004) Summary page 1.
- K002056: Micrus Microcoil Delivery System, MDS03, Micrus Corp. (2001) Summary page 1.

## Most influential descendants
- K062036: Micrus Microcoil System Presidio-18, Model PC4 (2006), 34 descendants of its own
- K070707: Micrus Microcoil System (2007), 32 descendants of its own
- K073442: Micrus Microcoil Systems (2008), 31 descendants of its own
- K081465: Axium Detachable Coil System (2008), 22 descendants of its own
- K123803: Reverse Medical Micro Vascular Plug (MVP) System (2013), 10 descendants of its own

## Indications for use
The Micrus Modified Microcoil System, "Cerecyte-18" is intended for endovascular embolization of intracranial aneurysms.

Source page: https://510kreport.com/device/K053160
Methodology: https://510kreport.com/methodology